Report on therapy
Adverse reactions to nitrofurantoin: Analysis of 921 reports

https://doi.org/10.1016/0002-9343(80)90443-XGet rights and content

Abstract

Reports on adverse reactions to nitrofurantoin today are common in Sweden and constitute 10 to 12 percent of all incoming reports. We present an analysis of 921 reports of adverse reactions received by the Swedish Adverse Drug Reaction Committee during the period 1966–1976. The two largest groups consist of reports of acute pulmonary reactions (43 percent) and allergic reactions (42 percent). The remaining reports fall into any of four smaller groups, chronic pulmonary reactions, liver damage, blood dyscrasias or neuropathy. Acute pulmonary and acute allergic reactions in all aspects are very similar and carry the characteristics of an acute hypersensitivity reaction. The increasing number of reports—even in relation to sales figures—would be best explained by a continuous sensitization. Chronic pulmonary reactions (interstitial pneumonitis) afflict older patients, often after prolonged treatment with relatively small doses. We suggest that these reactions are elicited by a toxic mechanism. Seventy-one percent of all reactions were severe enough to cause the patient's hospitalization; only 1 percent was fatal. The risk of an adverse reaction varies with sex and age, increases with age and is higher in women than in men. The time has come for a re-evaluation of nitrofurantoin and its role in the treatment of urinary tract infections.

References (15)

  • MR Boyd et al.

    Metabolic activation of nitrofurantoin—possible implications for carcinogenesis

    Biochem Pharmacol

    (1979)
  • D Slone et al.

    Drug evaluation after marketing

    Ann Intern Med

    (1979)
  • LE Böttiger et al.

    Adverse drug reactions during treatment of urinary tract infections

    Eur J Clin Pharmacol

    (1977)
  • LE Böttiger

    Adverse drug reactions

    J Clin Pharmacol

    (1973)
  • LE Böttiger et al.

    Drug-induced cytopenias in Sweden

    Br Med J

    (1973)
  • K Kristoferson et al.

    A three-year prescription study (in Swedish)

    Sven Farmaceutisk Tidskri

    (1977)
  • Holmberg L, Boman G: Pulmonary reactions to nitrpfurantoin in Sweden 1966-76. Submitted to Eur J Respir...
There are more references available in the full text version of this article.

Cited by (194)

  • Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study

    2022, Clinical Microbiology and Infection
    Citation Excerpt :

    Given our relatively short follow-up period, we may have missed consultations for chronic pneumonitis. If recognized early with discontinuation of nitrofurantoin, prognosis of both entities is on average good; however, serious irreversible lung damage could also occur and fatalities have been described [19,20]. It was already known that macrocrystalline nitrofurantoin prophylaxis is associated with a higher incidence of gastrointestinal adverse events when compared with other antimicrobials, with relative ratios of 2.24 (95% CI 1.77–2.83) and 2.17 (95% CI 1.34-3.50) in two meta-analyses [8,9,21].

  • Drug-Induced Liver Injury

    2022, Comprehensive Pharmacology
  • Nitrofurantoin

    2022, Comprehensive Pharmacology
  • Respiratory

    2020, An Introduction to Interdisciplinary Toxicology: From Molecules to Man
View all citing articles on Scopus
1

From the Departments of Medicine and Thoracic Medicine, Karolinska Hospital, Stockholm.

3

From the National Corporation of Pharmacies, Stockholm, Sweden.

2

From the Adverse Drug Reaction Committee, National Board of Health and Welfare, Uppsala; Pharmacia Norden Inc., Uppsala.

View full text